Phase II Study of Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2017
This article has no abstract
Epistemonikos ID: b10bbbba9eab10e0aaedad81393e2eaea9090ee6
First added on: Jan 23, 2025